Related Experiment Video
Updated: Jul 29, 2026
09:37
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning
X Yu1, S Chen, O L Potter
1Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Bone
|April 5, 2005
Summary
Neurofibromatosis type 1 (NF1) causes skeletal issues. In NF1 mice, osteoprogenitors show abnormal function and Ras signaling activation, impacting bone health.
Area of Science:
- Bone biology
- Genetics
- Cell signaling
Background:
- Neurofibromatosis type 1 (NF1) affects up to 50% of patients with skeletal problems and osteoporosis.
- NF1 is caused by neurofibromin inactivation, leading to Ras signal transduction deregulation.
- Bone biology in NF1 patients is not well understood.
Purpose of the Study:
- To investigate if Nf1 gene loss-of-function alters bone homeostasis and Ras signaling.
- To explore skeletal phenotypes and osteoprogenitor functions in Nf1 haploinsufficient mice.
Main Methods:
- Utilized heterozygote Nf1 (Nf1+/-) male mice due to embryonic lethality of homozygous Nf1 mice.
- Conducted standard in vivo and in vitro assays to assess bone mass, geometry, and osteoprogenitor function.
- Analyzed Ras signaling activation and osteoblast differentiation markers in Nf1+/- cells.
Main Results:
- Nf1+/- mice showed no significant differences in bone mass or geometry compared to wild-type controls.
- Nf1+/- osteoprogenitors exhibited increased proliferation and premature apoptosis.
- Activated Ras signaling and increased osteopontin (OPN) expression were observed in Nf1+/- osteoprogenitors and bone.
Conclusions:
- In vitro findings suggest neurofibromin and Ras signaling control are crucial for osteoprogenitor homeostasis.
- Redundant pathways likely compensate in vivo for Nf1 haploinsufficiency, maintaining normal bone mass.
- Further research is needed to understand the complex bone biology in NF1.
Related Concept Videos
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...